The company currently has 111 registered products, including 88 products in 13 dosage forms of formulated drugs and 23 whale-derived active pharmaceutical ingredients. Currently, another 25 formulations of formulated drug products have obtained registration certificates in 20 countries.

The company's pharmaceutical preparations are predominantly generic drugs, but these products are what the general public needs and loves. The company has always been committed to continuously improving product quality and enhancing the overall quality of its products. Based on market demand, it produces nearly 50 domestic preparations throughout the year. The types of oral medications include antibacterial drugs, vitamins, antipyretic analgesics, cardiovascular and cerebrovascular drugs, gastrointestinal and digestive system drugs, cough and asthma relievers, contraceptives, etc. Topical medications mainly include ophthalmic ointments, external ointments, lotions, etc. The company's main pharmaceutical preparations are nifedipine sustained-release tablets, montmorillonite suspension, compound licorice series, aureomycin/erythromycin ophthalmic ointment, ketoconazole lotion, etc.

　　The main active pharmaceutical ingredients (APIs) produced by the company throughout the year include levamisole hydrochloride, ketoconazole, and calcium ketate series products. The company has been exporting pharmaceutical preparations since 2004, mainly including tablets, ointments, sterile ophthalmic ointments, suspensions, contraceptives, intermediate particles, and other products, with over 50 specifications. The products are sold to more than 40 countries and regions.